PLSE

Conviction 86HealthcareScan · Thu, Jun 25, 2026

PLSE$27.51+7.44%

ResistanceSupportVol 14Insider buy

Vol MA14 302.49K

Mar 26Apr 14May 1May 19Jun 8Jun 25

PULSE BIOSCIENCES, INC.SURGICAL & MEDICAL INSTRUMENTS & APPARATUSwww.pulsebiosciences.com ↗

Price27.51

Change+7.44%

Gap-0.82%

Rel volume1.42×

Avg volume304.11K

Avg $ vol7.8M

SMA 2025.48

SMA 5023.85

SMA 20018.84

Price vs 50+15.31%

Price vs 200+45.98%

MA stackbullish

50/200 cross—

Supertrendup · 21.35

RSI (14)60

MACD hist0.01

MACD crossbull · 0d

Stoch %K / %D77 / 52

ADX (14)42

+DI / −DI25 / 6

RSI divergence—

MACD divergence—

ATR %+6.43%

ADR %6.90%

52w high27.51

52w low12.66

From 52w high+0.00%

Above 52w low+117.26%

New 52w highYes

SqueezeOn · 12d

Bollinger width13.11%

%B1.10

Donchian pos79.21%

Donchian high28.53

Donchian low23.60

AVWAP (52w high)25.93

vs AVWAP high+6.07%

AVWAP (52w low)20.69

vs AVWAP low+32.95%

OBV trendUp

Chaikin MF (20)0.02

Today vs 20d1.42×

Avg vol (14d)302.49K

Avg vol (20d)304.11K

Avg $ vol (20d)7.8M

Market cap1.9B

RS 3m (vs SPY)+7.99%

RS 6m (vs SPY)+60.02%

RS line new highNo

Trend template8/8

Technical rank92.1

1 week+8.07%

1 month+5.79%

3 months+24.91%

6 months+80.95%

1 year+78.60%

YTD+105.41%

P/E-26.16

P/B28.71

P/S—

P/FCF-34.97

EPS-1.08

Div yield—

ROE-109.78%

ROA-89.17%

Debt/Eq—

Current7.26

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth-35.82%

Price target31.00

Target upside12.71%

Analyst ratingBuy

Institutional12.91%

Ent. value1.84B

Revenue401K

Net income-18.58M

Gross profit—

Free cash flow-54.44M

IndustrySURGICAL & MEDICAL INSTRUMENTS & APPARATUS

ExchangeNasdaq

Shares out69.21M

Employees116

ListedWed, May 18, 2016

Free float18.17M

Float %26.6%

Short interest3.09M

Days to cover10.5d

Short volume52.2%

Squeeze score73 / 100

Next earnings—

EPS forecast—

Last EPS vs est−$0.27 vs −$0.32

Last surprise+15.6% beat

Setup gradeA+

Conviction86 / 100

Pattern quality—

Tech rank92.1 / 100

Group rank50 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance28.51

Support20.98

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in PLSE

All disclosures →

No recent disclosed trades by Congress in PLSE. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in PLSE · 4 buys

Insider	Side	Shares	Value	Traded	Filed
DUGGAN ROBERT W Director · Common Stock · 2026-05-11	Buy	660.23K	$13M	2026-05-11	2026-05-15
DUGGAN ROBERT W Director · Common Stock · 2026-05-11	Other	—	—	2026-05-11	2026-05-15
LAVIOLETTE PAUL A Chief Executive Officer · Common Stock · 2026-05-11	Buy	15K	$295K	2026-05-11	2026-05-11
LAVIOLETTE PAUL A Chief Executive Officer · Common Stock · 2026-05-11	Buy	15K	$295K	2026-05-11	2026-05-11
DUGGAN ROBERT W Director · Common Stock · 2026-05-11	Other	—	—	2026-05-11	2026-05-11
DUGGAN ROBERT W Director · Common Stock · 2026-05-11	Buy	660.23K	$13M	2026-05-11	2026-05-11

SEC filings

EDGAR filings in PLSE · 2 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.